Article Details

Tech-Driven Pharma Company TrialSpark Secures $156 Million In Series C Funding - Pulse 2.0

Retrieved on: 2021-10-10 03:10:23

Tags for this article:

Click the tags to see associated articles and topics

Tech-Driven Pharma Company TrialSpark Secures $156 Million In Series C Funding - Pulse 2.0. View article details on hiswai:

Excerpt

... including Sequoia Capital (Series A lead), Thrive Capital (Series B lead), Casdin Capital, Dragoneer, Section 32, John Doerr, Spark Capital, ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up